Speaker illustration

Professor Takeshi Soeki

Tokushima University, Tokushima (Japan)

Toll-like receptor 9 is a novel therapeutic target to prevent atrial fibrillation

Event: ESC Congress 2020

Topic: Pathophysiology and Mechanisms

Session: Atrial Fibrillation ePosters

Thumbnail

Vildagliptin reduces inducibility of atrial fibrillation in hypertensive rats complicated with diabetes mellitus

Event: ESC Congress 2019

Topic: Antiarrhythmic Drug Treatment

Session: Basic science atrial fibrillation

Thumbnail

C-type natriuretic peptide improves left ventricular diastolic dysfunction and ischemia/reperfusion injury-associated ventricular arrhythmias

Event: ESC Congress 2018

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure – pathophysiology and mechanisms

Thumbnail

Increased local production of C-type natriuretic peptide in patients with vasospastic angina

Event: ESC Congress 2016

Topic: Ischaemia, experimental studies

Session: Experimental studies on ischaemia

Thumbnail

ESC 365 is supported by